Has Nicolina Scibelli received payments from drug or device companies?

Yes. Drug and device makers reported $6,407 in general payments to Nicolina Scibelli across 243 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Nicolina Scibelli did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Nicolina Scibelli come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Nicolina Scibelli

Hematology & Oncology · Myrtle Beach, SCNPI 1528527546

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.1% of the total across 243 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 54 manufacturers, the largest accounting for just 8.9% — the pattern of someone who eats at a lot of different presentations.

$6,407in general payments, 2019–2025

Across 243 payments — averaging $26.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Incyte Corporation$569
Takeda Pharmaceuticals U.S.A., Inc.$392
Astellas Pharma US Inc$386
AstraZeneca$370
Merck$333
Johnson & Johnson$327
plus $4K from 48 others

What the payments were for

Food & beverage$6,09395%
Education$3145%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Incyte Corporation	27	$569
Takeda Pharmaceuticals U.S.A., Inc.	20	$392
Astellas Pharma US Inc	13	$386
AstraZeneca(2 entities)	13	$370
Merck	15	$333
Johnson & Johnson	16	$327
Bristol Myers Squibb	12	$231
Seagen Inc.	6	$224
Rigel Pharmaceuticals, Inc.	4	$222
Novartis	12	$222
Aurinia Pharma U.S., Inc.	2	$215
Sanofi	11	$214
Gilead	2	$195
Genentech USA, Inc.	3	$166
Novocure Inc.	2	$152
Regeneron Healthcare Solutions, Inc.	2	$152
Beigene USA, Inc.	4	$146
E.r. Squibb & Sons, L.L.C.	2	$144
AbbVie	6	$121
Daiichi Sankyo Inc.	2	$117
Pfizer	6	$103
Sanofi-aventis U.S. LLC	2	$93
Caris MPI, Inc.	1	$80
Bayer	3	$79
Karyopharm Therapeutics Inc.	4	$72
Beone Medicines USA, Inc.	3	$70
Puma Biotechnology, Inc.	4	$66
Stemline Therapeutics Inc.	3	$66
Sobi, Inc	3	$65
ADC Therapeutics America, Inc.	3	$57
GSK	3	$51
Genmab U.S., Inc.	3	$48
HEMA Biologics, LLC	2	$47
Baxter Healthcare	1	$46
Novo Nordisk	2	$46
Adaptive Biotechnologies Corporation	2	$45
AVEO Pharmaceuticals, Inc.	2	$40
Lilly USA, LLC	2	$40
Acrotech Biopharma Inc.	2	$38
Jazz Pharmaceuticals Inc.	2	$38
Boehringer Ingelheim	2	$32
Janssen Scientific Affairs, LLC	1	$31
EMD Serono, Inc.	2	$31
Pharmacosmos Therapeutics Inc.	1	$28
Azurity Pharmaceuticals, Inc.	1	$25
Kyowa Kirin, Inc.	1	$25
Pharmaessentia USA Corporation	1	$23
Exelixis Inc.	1	$21
G1 Therapeutics, Inc.	1	$21
Taiho Oncology, Inc.	1	$20
Geron Corporation	1	$19
Recordati_rare_diseases_inc.	1	$18
Array Biopharma Inc	1	$17
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	1	$6

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,407 in reported general payments places this provider in the 55th percentile of 166 hematology & oncology providers in South Carolina.

See all hematology & oncology providers in South Carolina →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	13	$269
Ondansetron Hcl	17	$208
Letrozole	15	$138
Gabapentin	11	$130

Paid to pharmacies, not to this prescriber.

Other hematology & oncology in Myrtle Beach

Emily TouloukianMyrtle Beach$20K
Suzanne FanningGreenville$927K
Vikas DemblaSpartanburg$568K
Stephen DyarGreenville$413K
Kashyap PatelRock Hill$379K
Tondre BuckSpartanburg$366K
Bhumika PatelGreenville$225K
Ming LimCharleston$94K
George GeilsCharleston$76K
Joe StephensonGreenville$57K

See the full list for South Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →